同步行食管癌切除术和肝切除术治疗转移性食管癌：病例报告
Synchronous oesophagectomy and hepatic resection for metastatic oesophageal cancer: report of a case.
作者信息
Mudan S S, Giakoustidis A, Giakoustidis D, Slevin M
出版信息
Hippokratia. 2010 Oct;14(4):291-3.
Abstract
BACKGROUND
Oesophageal cancer with liver metastasis is rare and when diagnosed is usually advanced and surgical management is contraindicated.Method-Results: We report the case of a patient who presented with oesophageal cancer and liver metastasis. The patient received chemotherapy combined with RFA to liver tumour. Subsequently she was subjected to oesophagectomy and liver resection of segment 5 extended into segment 8. Patient underwent adjuvant chemotherapy post-operatively and remains disease-free until now, 29 months after operation.
CONCLUSION
Oesophageal cancer with concomitant liver metastasis is a rare and lethal disease. Multimodal management including surgery may offer prolonged survival in highly selected patients.
摘要
背景
伴有肝转移的食管癌较为罕见，一旦确诊通常已属晚期，手术治疗为禁忌。
方法-结果：我们报告一例伴有食管癌和肝转移的患者。该患者接受了化疗联合肝脏肿瘤射频消融治疗。随后她接受了食管切除术以及将第5肝段扩展至第8肝段的肝切除术。患者术后接受了辅助化疗，至今术后29个月仍无疾病复发。
结论
伴有肝转移的食管癌是一种罕见且致命的疾病。包括手术在内的多模式治疗可能为经过严格筛选的患者延长生存期。
相似文献
1
Synchronous oesophagectomy and hepatic resection for metastatic oesophageal cancer: report of a case.同步行食管癌切除术和肝切除术治疗转移性食管癌：病例报告
Hippokratia. 2010 Oct;14(4):291-3.
2
Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature.成功切除食管鳞状细胞癌胰腺转移：病例报告及文献复习。
BMC Cancer. 2019 Apr 5;19(1):320. doi: 10.1186/s12885-019-5549-9.
3
Hepatic resection for post-operative solitary liver metastasis from oesophageal squamous cell carcinoma.肝切除术治疗食管鳞状细胞癌术后孤立性肝转移
ANZ J Surg. 2018 Apr;88(4):E252-E256. doi: 10.1111/ans.13810. Epub 2016 Oct 20.
4
[Radiofrequency ablation of colorectal liver metastases].[结直肠癌肝转移的射频消融术]
Zentralbl Chir. 2009 Apr;134(2):145-8. doi: 10.1055/s-2008-1076874. Epub 2009 Apr 20.
5
A rare case of bipartite combined tumour of the oesophagus.罕见的食管二部分联合性肿瘤病例。
World J Surg Oncol. 2019 May 6;17(1):79. doi: 10.1186/s12957-019-1623-7.
6
Oesophageal adenocarcinoma metastasis into a microcystic meningioma: a rare occurrence of tumour to tumour metastasis.食管腺癌转移至微囊性脑膜瘤：一种罕见的肿瘤至肿瘤转移情况。
BJR Case Rep. 2021 Dec 14;8(2):20210157. doi: 10.1259/bjrcr.20210157. eCollection 2022 Mar 10.
7
Primary gastric cancer in an oesophageal gastric graft after oesophagectomy.胃切除术后食管胃移植中发生原发性胃癌。
Eur J Cardiothorac Surg. 2011 Nov;40(5):1181-4. doi: 10.1016/j.ejcts.2011.02.061. Epub 2011 Aug 24.
8
Induction chemotherapy followed by surgery for advanced oesophageal cancer.晚期食管癌先行诱导化疗再行手术治疗。
Eur J Surg Oncol. 2015 Mar;41(3):323-32. doi: 10.1016/j.ejso.2014.11.043. Epub 2014 Dec 3.
9
Gastric conduit cancer after oesophagectomy for oesophageal cancer: incidence and clinical implications.食管癌食管切除术后胃代食管段癌：发病率及临床意义
Eur J Cardiothorac Surg. 2014 May;45(5):899-903. doi: 10.1093/ejcts/ezt497. Epub 2013 Oct 24.
10
Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.胃癌根治术在同步肝转移的晚期胃癌综合治疗中的应用：一项前瞻性对照研究。
World J Surg Oncol. 2015 Jul 1;13:212. doi: 10.1186/s12957-015-0627-1.
引用本文的文献
1
Outcomes after Surgical Treatment of Oesophagogastric Cancer with Synchronous Liver Metastases: A Multicentre Retrospective Cohort Study.同步肝转移的食管癌和胃癌手术治疗后的结局：一项多中心回顾性队列研究
Cancers (Basel). 2024 Feb 16;16(4):797. doi: 10.3390/cancers16040797.
2
A predictive scoring model to select suitable patients for surgery on primary tumor in metastatic esophageal cancer.预测评分模型选择适合转移性食管癌原发灶手术的患者。
Cancer Rep (Hoboken). 2023 Dec;6(12):e1898. doi: 10.1002/cnr2.1898. Epub 2023 Sep 13.
3
A machine learning model predicting candidates for surgical treatment modality in patients with distant metastatic esophageal adenocarcinoma: A propensity score-matched analysis.预测远处转移性食管腺癌患者手术治疗方式候选者的机器学习模型：倾向评分匹配分析
Front Oncol. 2022 Jul 22;12:862536. doi: 10.3389/fonc.2022.862536. eCollection 2022.
4
Treatment paradigms and survival outcomes in esophageal adenocarcinoma with liver metastasis: a retrospective cohort study using the SEER database.食管腺癌伴肝转移的治疗模式与生存结局：一项使用监测、流行病学和最终结果（SEER）数据库的回顾性队列研究
J Gastrointest Oncol. 2022 Jun;13(3):935-948. doi: 10.21037/jgo-22-420.
5
A Model for Identifying Optimal Patients for Primary Tumor Resection in Patients With Metastatic Bladder Cancer.一种用于识别转移性膀胱癌患者中原发性肿瘤切除最佳患者的模型。
Front Oncol. 2022 Jan 19;11:809664. doi: 10.3389/fonc.2021.809664. eCollection 2021.
6
A population-based predictive model predicting candidate for primary tumor surgery in patients with metastatic esophageal cancer.一种基于人群的预测模型，用于预测转移性食管癌患者原发性肿瘤手术的候选者。
J Thorac Dis. 2021 Feb;13(2):870-882. doi: 10.21037/jtd-20-2347.
7
Management of Liver Oligometastatic Esophageal Cancer: Overview and Critical Analysis of the Different Loco-Regional Treatments.肝寡转移食管癌的管理：不同局部区域治疗方法的概述与批判性分析
Cancers (Basel). 2019 Dec 19;12(1):20. doi: 10.3390/cancers12010020.
8
Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer.姑息性切除或放疗原发肿瘤可延长转移性食管癌患者的生存时间。
Cancer Med. 2019 Dec;8(17):7253-7264. doi: 10.1002/cam4.2609. Epub 2019 Oct 14.
本文引用的文献
1
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.转移性结直肠癌患者生存率的提高与肝切除的采用及化疗的改善有关。
J Clin Oncol. 2009 Aug 1;27(22):3677-83. doi: 10.1200/JCO.2008.20.5278. Epub 2009 May 26.
2
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study.西妥昔单抗联合伊立替康/5-氟尿嘧啶/亚叶酸钙（FOLFIRI）用于转移性结直肠癌的初始治疗：一项多中心两部分的I/II期研究。
BMC Cancer. 2009 Apr 14;9:112. doi: 10.1186/1471-2407-9-112.
3
Capecitabine and oxaliplatin for advanced esophagogastric cancer.卡培他滨与奥沙利铂用于晚期食管胃癌
N Engl J Med. 2008 Jan 3;358(1):36-46. doi: 10.1056/NEJMoa073149.
4
Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis.肝转移鳞状细胞癌的肝脏定向手术：一项多中心分析结果
Ann Surg Oncol. 2007 Oct;14(10):2807-16. doi: 10.1245/s10434-007-9467-8. Epub 2007 Jun 6.
5
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study).西妥昔单抗联合FOLFIRI治疗未经治疗的晚期胃或胃食管交界腺癌患者的II期研究（FOLCETUX研究）
Ann Oncol. 2007 Mar;18(3):510-7. doi: 10.1093/annonc/mdl459. Epub 2006 Dec 12.
6
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.结直肠癌肝转移患者肝切除、射频消融及联合切除/消融后的复发情况及预后
Ann Surg. 2004 Jun;239(6):818-25; discussion 825-7. doi: 10.1097/01.sla.0000128305.90650.71.
7
8
Esophagectomy and hepatic arterial chemotherapy following hepatic resection for esophageal cancer with liver metastasis.食管癌肝转移行肝切除术后的食管切除术及肝动脉化疗。
J Gastroenterol. 2001 Aug;36(8):560-3. doi: 10.1007/s005350170060.
9
Hepatic metastasis from esophageal cancer treated by surgical resection and hepatic arterial infusion chemotherapy.手术切除及肝动脉灌注化疗治疗食管癌肝转移
Hepatogastroenterology. 1998 Jan-Feb;45(19):201-5.
Zotero 插件